XML 50 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Note 9 - Segment and Geographic Data - Summary by Reporting and Operating Segments (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Product sales, net $ 2,232,420 $ 2,248,845  
Cost of products sold 584,985 572,742  
Gross Margin 1,647,435 1,676,103  
Salaries & employee benefits 764,720 862,952  
Stock-based compensation expense 330,788 313,505  
Royalty expense 112,491 115,692  
Marketing 112,211 113,624  
Rent & occupancy costs 33,054 30,608  
Consultants and professional services fees 1,284,647 939,399  
Insurance 134,305 150,825  
Warehousing expense 122,292 113,342  
Regulatory expense 84,051 103,498  
Travel expense 66,102 51,820  
Research and development expenses 369,120 94,211  
Depreciation and amortization expense 19,440 11,684  
Other segment items 212,067 240,011  
Total operating expenses 3,645,288 3,141,171  
Operating income (loss) (1,997,853) (1,465,068)  
Total Assets 9,088,016   $ 9,797,072
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]      
Product sales, net 0 0  
Cost of products sold 0 0  
Gross Margin 0 0  
Salaries & employee benefits 117,108 250,482  
Stock-based compensation expense 330,788 311,427  
Royalty expense 0 0  
Marketing 4,261 28,317  
Rent & occupancy costs 12,707 10,713  
Consultants and professional services fees 1,084,695 637,052  
Insurance 42,872 75,974  
Warehousing expense 1,205 2,538  
Regulatory expense 64,890 97,522  
Travel expense 4,473 20,893  
Research and development expenses 0 0  
Depreciation and amortization expense 19,440 11,684  
Other segment items 73,518 143,119  
Total operating expenses 1,755,957 1,589,721  
Operating income (loss) (1,755,957) (1,589,721)  
Total Assets 3,030,871   3,992,825
Dental Segment [Member] | Operating Segments [Member]      
Product sales, net 2,181,170 2,241,425  
Cost of products sold 584,896 568,296  
Gross Margin 1,596,274 1,673,129  
Salaries & employee benefits 441,497 409,582  
Stock-based compensation expense 0 0  
Royalty expense 109,928 115,321  
Marketing 83,629 76,989  
Rent & occupancy costs 12,521 12,243  
Consultants and professional services fees 57,662 82,699  
Insurance 48,997 44,913  
Warehousing expense 112,314 105,910  
Regulatory expense 16,849 5,976  
Travel expense 31,668 7,977  
Research and development expenses 364,807 93,952  
Depreciation and amortization expense 0  
Other segment items 137,048 92,057  
Total operating expenses 1,416,920 1,047,619  
Operating income (loss) 179,354 625,510  
Total Assets 5,647,891   5,359,734
Medical Segment [Member] | Operating Segments [Member]      
Product sales, net 51,250 7,420  
Cost of products sold 89 4,446  
Gross Margin 51,161 2,974  
Salaries & employee benefits 206,115 202,888  
Stock-based compensation expense 0 2,078  
Royalty expense 2,563 371  
Marketing 24,321 8,318  
Rent & occupancy costs 7,826 7,652  
Consultants and professional services fees 142,290 219,648  
Insurance 42,436 29,938  
Warehousing expense 8,773 4,894  
Regulatory expense 2,312 0  
Travel expense 29,961 22,950  
Research and development expenses 4,313 259  
Depreciation and amortization expense 0 0  
Other segment items 1,501 4,835  
Total operating expenses 472,411 503,831  
Operating income (loss) (421,250) $ (500,857)  
Total Assets $ 409,254   $ 444,513